What is AMYT's gross margin?

Amryt Pharma (AMYT) has a gross margin of 45% and a net margin of -34%.

What is AMYT's P/E ratio?

Track Amryt Pharma (AMYT) P/E ratio, ROE, and valuation metrics over time.

Where can I see AMYT's full financials?

See Amryt Pharma (AMYT) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

Amryt Pharma (AMYT) Financials — Revenue, Earnings, Cash Flow

Also trades as: AMYT.L (LSE) · $vol 0M

$14.70

Last traded 2023-04-21 — delisted

NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest

📊 Key Metrics

TTM

$244M

Revenue

+15.9% YoY

$-20M

Net Income

+77.2% YoY

$107M

Free Cash Flow

+219.7% YoY

44.9%

Gross Margin

-17.1%

Op. Margin

-34.0%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-6.3%

ROA-2.5%

ROIC-7.8%

Valuation

P/E-37.7

P/B2.1

EV/EBITDA109.7

Leverage

Debt/Equity0.66

Current Ratio1.57

Interest Cov.0.2x

Quality Scores

Piotroski F5/9

Altman Z0.62

Beneish M-3.28